kabutan

TERUMO CORPORATION(4543) Summary

4543
TSE Prime
TERUMO CORPORATION
2,175.0
JPY
-13.0
(-0.59%)
Apr 17, 3:30 pm JST
13.63
USD
Apr 17, 2:30 am EDT
Result
PTS
outside of trading hours
2,206
Apr 17, 11:54 pm JST
Summary Chart Historical News Financial Result
PER
23.5
PBR
2.11
Yield
1.38%
Margin Trading Ratio
1.25
Stock Price
Apr 17, 2026
Opening Apr 17, 9:00 am
2,149.5 JPY 13.50 USD
Previous Close Apr 16
2,188.0 JPY 13.77 USD
High Apr 17, 9:31 am
2,179.0 JPY 13.68 USD
Low Apr 17, 9:00 am
2,145.0 JPY 13.47 USD
Volume
3,543,900
Trading Value
7.69B JPY 0.05B USD
VWAP
2170.79 JPY 13.61 USD
Minimum Trading Value
217,500 JPY 1,363 USD
Market Cap
3.22T JPY 0.02T USD
Number of Trades
4,696
Liquidity & Number of Trades
As of Apr 17, 2026
Liquidity
High
1-Year Average
6,726
1-Year High Aug 8, 2025
20,550
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 10, 2026 149,400 1,341,100 8.98
Apr 3, 2026 149,000 1,398,700 9.39
Mar 27, 2026 627,200 1,539,300 2.45
Mar 19, 2026 280,700 1,738,200 6.19
Mar 13, 2026 155,600 1,784,000 11.47
Company Profile
TERUMO CORPORATION is a leading manufacturer of medical devices, with a strong presence in the cardiovascular field. The company holds a high global market share in catheters and heart-lung machines.
Sector
Precision Instruments
TERUMO CORPORATION is a major medical device manufacturer with its business divided into three segments: "Cardiac and Vascular Company," "Medical Care Solutions Company," and "Blood and Cell Technologies Company." The group consists of numerous consolidated subsidiaries and equity-method affiliates, operating globally with an overseas sales ratio approaching 80%. The company offers a wide range of products across various business fields, with a particular strength in cardiovascular care, providing comprehensive solutions to meet the needs of medical professionals.